Tradestie Institutional Equity Comparison Engine
EMR vs ABBNY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EMR Overall Edge
EMR Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Emerson Electric Co. (EMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EMR trades at 22.9x Forward P/E with 24.8% operating margin (+7.1% YoY revenue) versus ABBNY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, EMR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ABBNY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
EMR
EMR 22.9x vs ABBNY N/M Fwd P/E
Growth & Margin Winner
EMR
Op Margin 24.8% vs N/A ยท YoY +7.1% vs N/A
Momentum & Technical Winner
EMR
1Y +25.4% vs +16.4% ยท 52W Pos 78% vs 38%
Options & Structure Winner
EMR
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (N/A IV)
EMR
NYSE
Emerson Electric Co.
Electronic & Other Electrical Equipment (No Computer Equip)
$161.06
-3.2% 1D
Market Cap
$91.6B
1M Return
-0.25%
1Y Return
+25.38%
Forward P/E
22.9x
Unified AI Score
51.2 / 100
HOLD
Tech 40.0
Fund 48.0
Flow 59.0
Mom 45.9
ABBNY
US Equity
ABBNY
Institutional Equity
$83.75
+0.01% 1D
Market Cap
N/A
1M Return
-9.64%
1Y Return
+16.43%
Forward P/E
N/M
Unified AI Score
55.7 / 100
HOLD
Tech 83.0
Fund 56.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EMR +25.38%
ABBNY +16.43%
Spread: +10.69 pp (EMR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EMR TTM Op. Margin: 24.8%
ABBNY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EMR vs ABBNY. Trailing 12-month operating profitability (EMR 24.8% vs ABBNY N/A) and valuation multiples (EMR 22.9x vs ABBNY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EMR | ABBNY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $91.6B | N/A | Larger Scale | EMR |
| Trailing P/E Ratio Valuation | 34.9x | N/M | Lower Multiple | EMR |
| Forward P/E Ratio Valuation | 22.9x | N/M | Lower Multiple | EMR |
| Revenue Growth (YoY) Growth | +7.1% | N/A | Higher Growth | EMR |
| Operating Margin (TTM) Profitability | 24.8% | N/A | Higher Margin | EMR |
| Net Profit Margin Profitability | 14.2% | N/A | Higher Margin | EMR |
| Return on Equity (ROE) Capital Efficiency | 13.1% | N/A | Higher ROE | EMR |
| 52-Week Range Position Momentum | 78% ($123โ$172) | 38% ($67โ$110) | Stronger Trend | EMR |
| Beta / 30D Volatility Risk Regime | 1.45ฮฒ ยท 34% Vol | 1.81ฮฒ ยท 41% Vol | Lower Realized Risk | EMR |
| Unified Institutional Score Composite Signal | 51.2 / 100 (HOLD) | 55.7 / 100 (HOLD) | Higher Composite | ABBNY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EMR vs ABBNY Buy Guide
EMR
CONSOLIDATION
68d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
ABBNY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EMR nor ABBNY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.